Fred Telling, Director at ORAGENICS INC (OGEN), bought 82,173 shares at $0.29 ($24K) on 2022-05-24, disclosed to the SEC on 2022-05-25.
Open-market purchase of $24k OGEN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.29 | 3,500 | $1K | 4.3% |
| 2 | $0.29 | 78,673 | $23K | 95.7% |
| Total | $0.29 avg | 82,173 | $24K | 100% |
| Filing → |
| OGEN | SELL | 2024-12-09 | $1K | — | Filing → |
| OGEN | SELL | 2023-12-01 | $12K | — | Filing → |
| OGEN | BUY | 2022-06-21 | $3K | — | Filing → |